Price
Financials
Standalone, Rs crore| Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 26.54 | 23.73 | 21.12 | 19.36 | 18.79 | 35.11 | 38.76 | 31.47 |
| Expenses | 25.18 | 22.28 | 19.95 | 18.17 | 17.58 | 33.34 | 37.39 | 29.04 |
| Operating Profit | 1.36 | 1.45 | 1.17 | 1.19 | 1.21 | 1.77 | 1.37 | 2.43 |
| OPM % | 5.12% | 6.11% | 5.54% | 6.15% | 6.44% | 5.04% | 3.53% | 7.72% |
| Other Income | 0.08 | 0.00 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.68 | 0.64 | 0.83 | 0.62 | 0.69 | 0.72 | 0.53 | 0.93 |
| Depreciation | 0.00 | 0.07 | 0.04 | 0.06 | 0.05 | 0.06 | 0.06 | 0.05 |
| Profit before tax | 0.76 | 0.74 | 0.69 | 0.51 | 0.47 | 0.99 | 0.78 | 1.45 |
| Tax % | 27.63% | 27.03% | 27.54% | 27.45% | 27.66% | 29.29% | 26.92% | 28.28% |
| Net Profit | 0.55 | 0.54 | 0.50 | 0.38 | 0.34 | 0.70 | 0.57 | 1.04 |
| EPS in Rs | 24.36 | 1.84 | 1.24 | 0.95 | 0.85 | 1.74 | 1.42 | 2.59 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 36.66 | 55.63 | 50.19 | 40.67 | 53.73 | 70.13 |
| Expenses | 35.36 | 53.53 | 47.47 | 38.11 | 50.95 | 66.32 |
| Operating Profit | 1.30 | 2.10 | 2.72 | 2.56 | 2.78 | 3.81 |
| OPM % | 3.55% | 3.77% | 5.42% | 6.29% | 5.17% | 5.43% |
| Other Income | 0.09 | 0.32 | 0.16 | 0.19 | 0.19 | 0.02 |
| Interest | 0.33 | 0.80 | 1.32 | 1.45 | 1.41 | 1.49 |
| Depreciation | 0.02 | 0.05 | 0.07 | 0.09 | 0.11 | 0.11 |
| Profit before tax | 1.04 | 1.57 | 1.49 | 1.21 | 1.45 | 2.23 |
| Tax % | 28.85% | 28.03% | 28.86% | 27.27% | 28.97% | 27.80% |
| Net Profit | 0.73 | 1.14 | 1.06 | 0.88 | 1.03 | 1.61 |
| EPS in Rs | 730.00 | 50.49 | 3.61 | 2.19 | 2.56 | 4.00 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 14% | 12% | 31% | ||
| Compounded Profit Growth | % | 18% | 16% | 62% | ||
| Stock Price CAGR | % | % | -15% | -11% | ||
| Return on Equity | % | 12% | 9% | 10% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.23 | 2.94 | 4.02 | 4.02 | 4.02 |
| Reserves | 0.93 | 3.80 | 2.15 | 10.62 | 11.66 | 13.27 |
| Borrowings | 3.02 | 6.14 | 10.18 | 5.73 | 9.46 | 14.41 |
| Other Liabilities | 4.26 | 5.34 | 6.07 | 6.20 | 14.41 | 10.04 |
| Total Liabilities | 8.22 | 15.51 | 21.34 | 26.57 | 39.55 | 41.74 |
| Fixed Assets | 0.09 | 0.34 | 2.22 | 2.51 | 2.51 | 2.18 |
| CWIP | 0.00 | 0.00 | 1.79 | 6.13 | 8.61 | 20.34 |
| Investments | 0.00 | 0.04 | 0.14 | 0.20 | 0.34 | 0.54 |
| Other Assets | 8.13 | 15.13 | 17.19 | 17.73 | 28.09 | 18.68 |
| Total Assets | 8.22 | 15.51 | 21.34 | 26.57 | 39.55 | 41.74 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | -1.05 | -3.67 | 2.19 | 1.02 | 1.15 | 7.44 |
| Cash from Investing Activity | -0.05 | -0.34 | -4.82 | -4.76 | -2.70 | -11.68 |
| Cash from Financing Activity | 1.03 | 4.27 | 2.73 | 3.70 | 1.56 | 4.25 |
| Net Cash Flow | -0.07 | 0.26 | 0.10 | -0.04 | 0.01 | 0.01 |
| Free Cash Flow | -1.10 | -3.97 | -1.54 | -3.71 | -1.45 | -4.06 |
| CFO/OP | -58% | -154% | 96% | 53% | 56% | 212% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 71.88 | 91.73 | 80.80 | 145.75 | 180.56 | 90.04 |
| Inventory Days | 7.23 | 3.41 | 31.18 | 4.10 | 0.75 | 4.92 |
| Days Payable | 45.43 | 38.52 | 47.22 | 57.45 | 102.56 | 48.43 |
| Cash Conversion Cycle | 33.68 | 56.62 | 64.76 | 92.39 | 78.76 | 46.52 |
| Working Capital Days | 22.20 | 33.07 | 17.16 | 71.71 | 29.89 | 5.88 |
| ROCE % | 33.55% | 22.09% | 14.93% | 12.57% | 13.41% |
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% |
| Public | 26.99% | 26.98% | 26.98% | 26.98% | 26.98% | 26.98% |
| No. of Shareholders | 597 | 506 | 438 | 422 | 435 | 413 |
Fundamentals
Market Cap₹ 15.6 Cr.
Current Price₹ 38.9
Stock P/E9.37
Book Value₹ 43.0
ROCE13.4 %
ROE10.1 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)31%
Compounded Profit Growth (TTM)62%
Standalone figures.
Valuation
Market capRs 16 Cr
Enterprise valueRs 22 Cr
P/E (TTM)14.39x
Price to book4.07x
Price to sales0.29x
EV / EBITDA9.21x
EV / EBIT9.40x
EV / sales0.40x
Earnings yield6.95%
Profitability
Operating margin (excl. other income)3.77%
Operating margin (incl. other income)4.35%
EBITDA margin4.35%
Pre-tax margin2.82%
Net profit margin2.05%
ROE45.88%
ROCE33.55%
ROA9.61%
ROIC (approx.)17.21%
Tax rate28.03%
Other income / net worth7.94%
Growth
Sales growth (latest year)51.75%
Profit growth (latest year)56.16%
Per share
EPS (TTM)Rs 2.84
EPS (latest year)Rs 50.48
Book value per shareRs 10.02
Sales per shareRs 138.36
Cash flow per shareRs -9.13
Free cash flow per shareRs -10.10
Efficiency
Asset turnover3.59x
Fixed asset turnover163.62x
Inventory turnover107.17x
Inventory days3 days
Debtor days92 days
Debtors turnover3.98x
Creditor days48 days
Cash conversion cycle47 days
Working capital days6 days
Leverage
Total debtRs 6 Cr
Cash and bankRs 0 Cr
Net debtRs 6 Cr
Debt to equity1.52x
Net debt / EBITDA2.43x
Interest coverage2.96x
Owners' fund to total sources25.98%
Debt to assets39.59%
Cash flow
Cash from Operating Activity (latest year)Rs -4 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 4 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -4 Cr
FCFE (approx.: FCF + change in debt)Rs -1 Cr
Cash from ops / profit, 5 years1.42x
Statement figures
Net sales (TTM)Rs 56 Cr
Net sales (latest year)Rs 56 Cr
Operating profit excl. other income (latest year)Rs 2 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 2 Cr
PBDT (TTM)Rs 2 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 50 Cr
Total expenditure (latest year)Rs 54 Cr
Total income (latest year)Rs 56 Cr
Share capitalRs 0 Cr
ReservesRs 4 Cr
Shareholders' fundsRs 4 Cr
Total assetsRs 16 Cr
Net blockRs 0 Cr
InvestmentsRs 0 Cr
ReceivablesRs 14 Cr
InventoryRs 0 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)0.40
Ownership
Promoter holding73.02% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | SAROJA | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +2.5% | -2.8% | +5.3 pts |
| 1 month | +45.7% | -6.8% | +52.5 pts |
| 3 months | +21.8% | -7.6% | +29.4 pts |
| 6 months | +13.2% | +0.4% | +12.8 pts |
| 1 year | -39.6% | -9.9% | -29.7 pts |
| 3 years | -36.0% | +14.2% | -50.2 pts |
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was -252% of net profit over the last 2 years |
| explain | High accruals Profit exceeded operating cash by 31% of total assets in 2026 |
| explain | Receivables outrunning sales Receivables grew 94% vs sales +52% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹31 Cr +62.6% vs Mar 2024.
Net profit ₹1 Cr +173.7%.
Against our estimate for Mar 2026: sales -44.0%, profit -1.8% in line.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Pidilite Industries Ltd | 148,809 | 56.2 | 31.0 % |
| Gujarat Fluorochemicals Ltd | 48,402 | 78.4 | 9.64 % |
| Navin Fluorine International Ltd | 42,255 | 53.1 | 21.0 % |
| Aether Industries Ltd | 23,226 | 96.8 | 11.9 % |
| Deepak Nitrite Ltd | 20,854 | 26.3 | 11.4 % |
| Atul Ltd | 17,614 | 22.1 | 14.9 % |
| Aarti Industries Ltd | 17,045 | 32.6 | 6.86 % |
| Fine Organic Industries Ltd | 15,759 | 36.0 | 21.5 % |
| BASF India Ltd | 14,871 | 24.0 | 14.5 % |
| Privi Speciality Chemicals Ltd | 14,084 | 40.3 | 22.3 % |
| Anupam Rasayan India Ltd | 13,409 | 76.8 | 7.38 % |
| Vinati Organics Ltd | 12,173 | 24.4 | 21.4 % |
| Elantas Beck India Ltd | 10,820 | 60.9 | 21.2 % |
| Jubilant Ingrevia Ltd | 10,180 | 32.0 | 11.4 % |
| Alkyl Amines Chemicals Ltd | 9,111 | 40.5 | 16.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly traded
Quick answers
What is the market cap of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd (SAROJA) has a market capitalisation of Rs 15.6 Cr. at the 2026-09-30 close.
What is the P/E ratio of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd trades at a P/E of 9.37 on trailing twelve-month profit, at the 2026-09-30 close.
What were Saroja Pharma Industries India Ltd's latest quarterly results?
In the Mar 2026 quarter, Saroja Pharma Industries India Ltd sales was Rs 31 Cr (+62.6% vs Mar 2024) and net profit was Rs 1 Cr.
What is the 52-week high and low of Saroja Pharma Industries India Ltd?
The 52-week high is Rs 48.00 and the 52-week low is Rs 28.00.